Related Experiment Video
Updated: Aug 6, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells
Akinobu Maeda1, Koh-ichi Nakashiro, Shingo Hara
1Department of Urology, Organ Function Integrative Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.
Abstract:
Clinical studies with prostate cancer tissue indicate that alterations in androgen receptor (AR) or c-Met overexpression are associated with androgen-independent progression. We investigated the interaction between AR and c-Met signaling in human prostate cancer cells. Androgen withdrawal or AR-specific small interfering RNA significantly reduced the growth rate while each maneuver induced the expression of c-Met. Knockdown of both AR and c-Met expression markedly inhibited the cell growth. Furthermore, microarray analysis indicated that the activation of c-Met down-regulated the expression of DNA repair-related genes including 8-oxoguanine DNA glycosylase. Exogenous hepatocyte growth factor also induced the production of intracellular reactive oxygen species and resulted in the accumulation of DNA damages. These results suggested that the activation of c-Met signaling may lead to induction of spontaneous mutations or genomic instability, which may lead to the progression of androgen-independent state. Thus, c-Met signaling is utilized for survival and growth under the androgen-depleted condition.
Insights
Androgen receptor (AR) and c-Met signaling interact in prostate cancer. Inhibiting both AR and c-Met slows cancer growth and may prevent genomic instability in androgen-independent states.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer progression to an androgen-independent state is linked to androgen receptor (AR) alterations and c-Met overexpression.
- Understanding the interplay between AR and c-Met signaling is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the interaction between androgen receptor (AR) and c-Met signaling pathways in human prostate cancer cells.
- To determine the role of c-Met signaling in the progression of androgen-independent prostate cancer.
Main Methods:
- Utilized androgen withdrawal and AR-specific small interfering RNA (siRNA) to modulate AR signaling.
- Employed siRNA to knockdown both AR and c-Met expression.
- Conducted microarray analysis to assess gene expression changes.
- Measured intracellular reactive oxygen species (ROS) and DNA damage accumulation.
Main Results:
- Androgen withdrawal or AR knockdown reduced cell growth and induced c-Met expression.
- Simultaneous knockdown of AR and c-Met significantly inhibited prostate cancer cell growth.
- c-Met activation led to downregulation of DNA repair genes, including 8-oxoguanine DNA glycosylase.
- Hepatocyte growth factor (HGF) induced ROS production and DNA damage.
Conclusions:
- c-Met signaling activation contributes to genomic instability and spontaneous mutations in prostate cancer.
- c-Met signaling promotes survival and growth in androgen-depleted conditions, driving progression to an androgen-independent state.
- Targeting the c-Met pathway may offer a therapeutic approach for advanced prostate cancer.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Activation and Inactivation of G Proteins
The Ras Gene
Ras is a superfamily...
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade

